16717217

Source:http://linkedlifedata.com/resource/pubmed/id/16717217

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0004083, umls-concept:C0087111, umls-concept:C0165519, umls-concept:C0442818, umls-concept:C0751956, umls-concept:C1623117
pubmed:issue	10
pubmed:dateCreated	2006-5-23
pubmed:abstractText	Matrix metalloproteinase-9 (MMP9) is expressed in acute ischemic stroke and up-regulated by tissue plasminogen activator (tPA) in animal models. The authors investigated plasma MMP9 and its endogenous inhibitor, tissue inhibitor of metalloproteinase (TIMP1), in tPA-treated and -untreated stroke patients.
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/K23 NS42720, http://linkedlifedata.com/resource/pubmed/grant/M01-RR-01066, http://linkedlifedata.com/resource/pubmed/grant/R01-NS37074, http://linkedlifedata.com/resource/pubmed/grant/R01-NS38731, http://linkedlifedata.com/resource/pubmed/grant/R01-NS40529
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0401060
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Biological Markers, http://linkedlifedata.com/resource/pubmed/chemical/Fibrinolytic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Matrix Metalloproteinase 9, http://linkedlifedata.com/resource/pubmed/chemical/Tissue Inhibitor of..., http://linkedlifedata.com/resource/pubmed/chemical/Tissue Plasminogen Activator
pubmed:status	MEDLINE
pubmed:month	May
pubmed:issn	1526-632X
pubmed:author	pubmed-author:BarronMM, pubmed-author:Du?DD, pubmed-author:FurieK LKL, pubmed-author:KoroshetzW JWJ, pubmed-author:LIPKEHH, pubmed-author:LedererMM, pubmed-author:LeeHH, pubmed-author:NingMM, pubmed-author:SorensenA GAG, pubmed-author:WangXX, pubmed-author:ZihSS
pubmed:issnType	Electronic
pubmed:day	23
pubmed:volume	66
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1550-5
pubmed:dateRevised	2007-11-14
pubmed:meshHeading	pubmed-meshheading:16717217-Aged, pubmed-meshheading:16717217-Biological Markers, pubmed-meshheading:16717217-Brain, pubmed-meshheading:16717217-Brain Damage, Chronic, pubmed-meshheading:16717217-Brain Ischemia, pubmed-meshheading:16717217-Case-Control Studies, pubmed-meshheading:16717217-Convalescence, pubmed-meshheading:16717217-Echo-Planar Imaging, pubmed-meshheading:16717217-Enzyme Induction, pubmed-meshheading:16717217-Enzyme-Linked Immunosorbent Assay, pubmed-meshheading:16717217-Female, pubmed-meshheading:16717217-Fibrinolytic Agents, pubmed-meshheading:16717217-Follow-Up Studies, pubmed-meshheading:16717217-Hemorrhagic Disorders, pubmed-meshheading:16717217-Humans, pubmed-meshheading:16717217-Leukocyte Count, pubmed-meshheading:16717217-Male, pubmed-meshheading:16717217-Matrix Metalloproteinase 9, pubmed-meshheading:16717217-Middle Aged, pubmed-meshheading:16717217-Severity of Illness Index, pubmed-meshheading:16717217-Thrombolytic Therapy, pubmed-meshheading:16717217-Time Factors, pubmed-meshheading:16717217-Tissue Inhibitor of Metalloproteinase-1, pubmed-meshheading:16717217-Tissue Plasminogen Activator, pubmed-meshheading:16717217-Treatment Outcome
pubmed:year	2006
pubmed:articleTitle	Association between tPA therapy and raised early matrix metalloproteinase-9 in acute stroke.
pubmed:affiliation	Stroke Service, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
pubmed:publicationType	Journal Article, Comparative Study, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural